What is GeneDx Holdings Corp. worth?
With the base-case assumptions below, a discounted cash flow model on GeneDx Holdings Corp.'s reported free cash flow gives $15.07 per share. The share price was $88.40 on September 25, 2026, 487% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $8.61 | -90% |
| Base | 15.0% | 9.0% | $15.07 | -83% |
| Bull | 20.0% | 8.0% | $27.09 | -69% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $19.95 | $21.48 | $23.34 | $25.67 | $28.66 |
| 8.0% | $16.28 | $17.27 | $18.44 | $19.84 | $21.55 |
| 9.0% | $13.61 | $14.29 | $15.07 | $15.98 | $17.05 |
| 10.0% | $11.59 | $12.07 | $12.61 | $13.23 | $13.95 |
| 11.0% | $10.00 | $10.35 | $10.75 | $11.19 | $11.69 |
Where the presets come from
Base: years 1 to 5 grow at GeneDx Holdings Corp.'s revenue growth rate over the last 5 fiscal years (19.0% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions